Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
3.160
-0.100 (-3.07%)
May 13, 2025, 12:49 PM - Market open
Senti Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 33.8 | 48.28 | 35.93 | 57.62 | 56.03 | 30.54 | Upgrade
|
| Short-Term Investments | - | 0.34 | 0.04 | 42.15 | 1.16 | 0.03 | Upgrade
|
| Cash & Short-Term Investments | 33.8 | 48.61 | 35.97 | 99.77 | 57.19 | 30.56 | Upgrade
|
| Cash Growth | 41.94% | 35.15% | -63.95% | 74.45% | 87.13% | 71.42% | Upgrade
|
| Accounts Receivable | 0.13 | 0.16 | 0.11 | 0.63 | 0.48 | 0.32 | Upgrade
|
| Other Receivables | 2.09 | 1.65 | 17.59 | - | - | - | Upgrade
|
| Receivables | 2.22 | 1.81 | 17.7 | 0.63 | 0.48 | 0.32 | Upgrade
|
| Prepaid Expenses | 9.19 | 7.96 | 17.33 | 1.87 | 0.8 | - | Upgrade
|
| Other Current Assets | - | 0.58 | 0.2 | 0.31 | 1.72 | 0.83 | Upgrade
|
| Total Current Assets | 45.21 | 58.96 | 71.2 | 102.58 | 60.19 | 31.71 | Upgrade
|
| Property, Plant & Equipment | 33.94 | 35.24 | 41.61 | 69.78 | 33.08 | 16.14 | Upgrade
|
| Other Long-Term Assets | 3.63 | 3.64 | 6.67 | 8.43 | 3.43 | 0.5 | Upgrade
|
| Total Assets | 82.78 | 97.84 | 119.48 | 180.79 | 96.7 | 48.35 | Upgrade
|
| Accounts Payable | 1.56 | 1.45 | 1.25 | 1.37 | 5.19 | 0.91 | Upgrade
|
| Accrued Expenses | 3.84 | 6.27 | 5.93 | 12.58 | 5.33 | 2 | Upgrade
|
| Current Portion of Leases | 4.81 | 4.75 | 4.13 | 1.99 | 1.74 | 1.52 | Upgrade
|
| Current Unearned Revenue | 0.51 | 0.66 | 0.99 | 0.8 | 1.66 | - | Upgrade
|
| Other Current Liabilities | - | 0.01 | 0.38 | 1.32 | 0.63 | 0.44 | Upgrade
|
| Total Current Liabilities | 10.73 | 13.15 | 12.67 | 18.05 | 14.54 | 4.87 | Upgrade
|
| Long-Term Leases | 27.63 | 28.89 | 33.54 | 35.1 | 20.99 | 12.53 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 0.18 | - | Upgrade
|
| Other Long-Term Liabilities | 6.56 | 5.05 | 6.36 | 0.37 | 0.62 | - | Upgrade
|
| Total Liabilities | 44.92 | 47.09 | 52.57 | 53.53 | 36.33 | 17.4 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | - | 0 | Upgrade
|
| Additional Paid-In Capital | 349.1 | 322.78 | 311.26 | 300.54 | 3.62 | 1.04 | Upgrade
|
| Retained Earnings | -311.25 | -297.13 | -244.34 | -173.29 | -115.08 | -59.76 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 0 | - | - | Upgrade
|
| Total Common Equity | 37.86 | 25.65 | 66.91 | 127.26 | -111.46 | -58.71 | Upgrade
|
| Shareholders' Equity | 37.86 | 50.76 | 66.91 | 127.26 | 60.38 | 30.95 | Upgrade
|
| Total Liabilities & Equity | 82.78 | 97.84 | 119.48 | 180.79 | 96.7 | 48.35 | Upgrade
|
| Total Debt | 32.45 | 33.64 | 37.67 | 37.09 | 22.73 | 14.05 | Upgrade
|
| Net Cash (Debt) | 1.36 | 14.97 | -1.7 | 62.68 | 34.46 | 16.51 | Upgrade
|
| Net Cash Growth | - | - | - | 81.89% | 108.68% | 446.97% | Upgrade
|
| Net Cash Per Share | 0.23 | 3.26 | -0.38 | 24.01 | 118.33 | 11.91 | Upgrade
|
| Filing Date Shares Outstanding | 26.08 | 26 | 4.57 | 4.42 | 1.52 | 1.45 | Upgrade
|
| Total Common Shares Outstanding | 26 | 4.83 | 4.57 | 4.41 | 1.52 | 1.45 | Upgrade
|
| Working Capital | 34.49 | 45.82 | 58.53 | 84.53 | 45.65 | 26.84 | Upgrade
|
| Book Value Per Share | 1.46 | 5.31 | 14.64 | 28.88 | -73.38 | -40.48 | Upgrade
|
| Tangible Book Value | 37.86 | 25.65 | 66.91 | 127.26 | -111.46 | -58.71 | Upgrade
|
| Tangible Book Value Per Share | 1.46 | 5.31 | 14.64 | 28.88 | -73.38 | -40.48 | Upgrade
|
| Machinery | - | 8.18 | 8.87 | 8.56 | 5.54 | 3.91 | Upgrade
|
| Construction In Progress | - | - | - | 43.89 | 8.05 | 0.23 | Upgrade
|
| Leasehold Improvements | - | 22.66 | 22.65 | 1.87 | 0.43 | 0.16 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.